LB Pharmaceuticals Inc (LBRX)

NASDAQ: LBRX · Real-Time Price · USD

45.33

-0.52 (-1.13%)

Aug 11, 2026, 4:00 PM EDT - Market closed

LB Pharmaceuticals Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Assets

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Jun '26 Jun 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022
Cash & Equivalents	283.11	250.17	22.98	14.98	21.4
Short-Term Investments	44.68	45.04	5.02	28.31	-
Cash & Short-Term Investments	327.79	295.21	28	43.29	21.4
Cash Growth	2204.32%	954.37%	-35.32%	102.26%	-
Other Current Assets	27.51	13.22	0.88	2.34	0.09
Total Current Assets	355.3	308.43	28.88	45.63	21.49
Net Property, Plant & Equipment	5.61	3.73	4.16	0.02	0
Other Long-Term Assets	0.78	0.77	0.5	-	-
Total Assets	361.69	312.93	33.53	45.66	21.49

Liabilities

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Jun '26 Jun 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022
Accounts Payable	3.49	2.13	2.32	1.39	0.16
Accrued Expenses	19.23	4.59	5.3	1.22	0.31
Current Portion of Leases	0.84	0.73	0.49	-	-
Total Current Liabilities	23.56	7.44	8.11	2.61	0.47
Long-Term Debt	-	-	-	-	24.15
Long-Term Leases	4.37	2.84	3.22	-	-
Other Long-Term Liabilities	1.41	1.34	2.5	1.56	18.49
Total Long-Term Liabilities	5.78	4.18	5.72	1.56	42.64
Total Liabilities	29.35	11.62	13.83	4.16	43.11

Shareholders' Equity

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Jun '26 Jun 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022
Common Stock	0	0	0	0	0
Additional Paid-in Capital	532.34	430.67	9.66	6.47	6.13
Accumulated Other Comprehensive Income	0.19	0.17	0.11	0.27	-
Retained Earnings	-200.19	-129.53	-104.32	-41.22	-34.95
Total Common Shareholders' Equity	332.35	301.31	-94.55	-34.47	-28.81
Minority Interest	-	-	114.26	75.97	7.19
Shareholders' Equity	332.35	301.31	19.71	41.49	-21.62
Total Liabilities & Equity	361.69	312.93	33.53	45.66	21.49

Additional Metrics

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Jun '26 Jun 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022
Total Debt	5.22	3.57	3.7	0	24.15
Net Cash (Debt)	322.57	291.64	24.3	43.29	-2.74
Net Cash Growth	2982.69%	1100.38%	-43.88%	-	-
Net Cash Per Share	14.40	36.25	67.82	150.75	-11.88
Book Value	332.35	301.31	-94.55	-34.47	-28.81
Book Value Per Share	14.84	37.45	-263.95	-120.05	-124.68
Tangible Book Value	332.35	301.31	-94.55	-34.47	-28.81
Tangible Book Value Per Share	14.84	37.45	-263.95	-120.05	-124.68

SEC Filings: 10-K · 10-Q